Phase II trial of weekly paclitaxel in patients with advanced melanoma
Phase II trial of weekly paclitaxel in patients with advanced melanoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Phase II trial of weekly paclitaxel in patients with advanced melanoma have?
Phase II trial of weekly paclitaxel in patients with advanced melanoma has 37 citations in the OpenAlex counts ScholarIQ stores.
When was Phase II trial of weekly paclitaxel in patients with advanced melanoma published?
Phase II trial of weekly paclitaxel in patients with advanced melanoma has 2005 year in the ScholarIQ index.
What is the open-access status of Phase II trial of weekly paclitaxel in patients with advanced melanoma?
Phase II trial of weekly paclitaxel in patients with advanced melanoma has closed oa status in the ScholarIQ index.
What is the DOI of Phase II trial of weekly paclitaxel in patients with advanced melanoma?
The DOI for Phase II trial of weekly paclitaxel in patients with advanced melanoma is on the source record.
What is the PMID of Phase II trial of weekly paclitaxel in patients with advanced melanoma?
The PMID for Phase II trial of weekly paclitaxel in patients with advanced melanoma is on the source record.
What is the OpenAlex record for Phase II trial of weekly paclitaxel in patients with advanced melanoma?
The OpenAlex for Phase II trial of weekly paclitaxel in patients with advanced melanoma is on the source record.